Related Experiment Video

Updated: Jun 24, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

TRIM32 is an E3 ubiquitin ligase for dysbindin

Matthew Locke1, Caroline L Tinsley, Matthew A Benson

  • 1Department of Psychological Medicine, Cardiff University, Cardiff, UK.

Human Molecular Genetics
|April 8, 2009
PubMed

Insights

Tripartite motif protein 32 (TRIM32) mutations cause muscular dystrophy and Bardet-Biedl syndrome. TRIM32 ubiquitinates and degrades dysbindin, and disease-linked mutations impair this function.

Area of Science:

  • Biochemistry
  • Genetics
  • Cell Biology

Background:

  • Mutations in tripartite motif protein 32 (TRIM32) cause limb-girdle muscular dystrophy type 2H (LGMD2H)/sarcotubular myopathy (STM) and Bardet-Biedl syndrome type 11 (BBS11).
  • The precise substrates and molecular mechanisms of TRIM32 in disease pathogenesis remain unclear.
  • TRIM32 functions as a ubiquitin ligase, a process crucial for protein regulation.

Purpose of the Study:

  • To investigate the substrates and function of TRIM32 in skeletal muscle.
  • To elucidate the molecular consequences of disease-associated TRIM32 mutations.
  • To identify TRIM32's role in regulating dysbindin levels.

Main Methods:

  • Yeast two-hybrid system to identify TRIM32 binding partners.
  • Ubiquitination assays to assess TRIM32 ligase activity.
  • Small-interfering RNA (siRNA) knockdown in myoblasts.
  • Immunoprecipitation and Western blotting to analyze protein interactions and levels.
  • Expression and localization studies in heterologous cells.

Main Results:

  • TRIM32 was identified as a ubiquitin ligase that binds and ubiquitinates dysbindin, promoting its degradation.
  • Knockdown of TRIM32 led to increased dysbindin levels in myoblasts.
  • LGMD2H/STM-associated mutations (D487N, R394H) impaired TRIM32's ubiquitin ligase activity towards dysbindin and caused mislocalization.
  • Mutant TRIM32 proteins could self-associate and interact with wild-type TRIM32.
  • The D487N mutant showed defects in monoubiquitination of dysbindin despite binding to the substrate and E2 enzyme.
  • The BBS11-associated mutation (P130S) did not exhibit significant biochemical differences from wild-type TRIM32.

Conclusions:

  • TRIM32 regulates dysbindin levels through ubiquitination and degradation.
  • LGMD2H/STM-associated TRIM32 mutations impair its ability to ubiquitinate dysbindin, potentially contributing to disease pathology.
  • TRIM32's role as a ubiquitin ligase for dysbindin provides a molecular link between muscular dystrophy and potentially other neurological conditions associated with dysbindin.

More Related Videos

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta10:27

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta

Published on: December 5, 2019

In-vitro Reconstitution of Bacterial Ubiquitination and VCP/p97-mediated Elimination07:58

In-vitro Reconstitution of Bacterial Ubiquitination and VCP/p97-mediated Elimination

Published on: January 2, 2026

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...